New York, NY, United States of America

Kamlesh Yadav

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: New York University. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamlesh Yadav. Retrieved from https://idiyas.com/inventor/kamlesh-yadav

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kamlesh Yadav: Innovator in Peptide Modulation

Introduction

Kamlesh Yadav is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of peptide modulation, particularly in relation to Ras proteins. With a total of 2 patents, his work is recognized for its innovative approach to biochemistry.

Latest Patents

Yadav's latest patents focus on "Hydrogen bond surrogate macrocycles as modulators of Ras." These inventions relate to peptides that possess one or more stable, internally-constrained HBS α-helices. The peptides are designed to interact effectively with Ras and related proteins, showcasing Yadav's expertise in the field.

Career Highlights

Kamlesh Yadav is affiliated with New York University, where he continues to advance research in peptide modulation. His work has garnered attention for its potential applications in therapeutic settings, particularly in cancer research.

Collaborations

Yadav has collaborated with notable colleagues, including Paramjit S Arora and Dafna Bar-Sagi. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Kamlesh Yadav's innovative work in peptide modulation and his contributions to the understanding of Ras proteins highlight his importance as an inventor. His patents reflect a commitment to advancing scientific knowledge and potential therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…